ScholarIQanswers from OpenAlex & ORCID
Jorien van der Schaft
ResearcherPublications, citations & collaboration network
Jorien van der Schaft is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jorien van der Schaft have?
ScholarIQindexed works
Jorien van der Schaft has 40 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jorien van der Schaft have?
ScholarIQcitation count
Jorien van der Schaft has 1,590 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jorien van der Schaft?
ScholarIQh-index
Jorien van der Schaft has an h-index of 19 in OpenAlex.
What is the i10-index of Jorien van der Schaft?
ScholarIQi10-index
Jorien van der Schaft has an i10-index of 24 in OpenAlex.
What is the OpenAlex record for Jorien van der Schaft?
ScholarIQopenalex
The OpenAlex for Jorien van der Schaft is on the source record.
What are the most-cited papers on Jorien van der Schaft?
ScholarIQmost cited works
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Eric L. Simpson, Marjolein de Bruin‐Weller, Carsten Flohr, Michael R. Ardern‐Jones, S. Barbarot, Mette Deleuran, Thomas Bieber, Christian Vestergaard, Sara Brown, Michael J. Cork, Aaron M. Drucker, Lawrence F. Eichenfield, R. Foelster‐Holst, Emma Guttman‐Yassky, Audrey Nosbaum, Nick J. Reynolds, Jonathan I. Silverberg, Jochen Schmitt, Marieke M.B. Seyger, Phyllis I. Spuls, Jean-Francois Stalder, John Su, Roberto Takaoka, Claudia Traidl‐Hoffmann, Jacob P. Thyssen, Jorien van der Schaft, Andreas Wollenberg, Alan D. Irvine, Amy S. Paller
The association between vitamin D and cognition: A systematic review
Jorien van der Schaft, Huiberdina L. Koek, Esmée A. Dijkstra, H. J. J. Verhaar, Yvonne T. van der Schouw, Mariëlle H. Emmelot‐Vonk
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Daphne S. Bakker, Lieneke F.M. Ariëns, C. van Luijk, Jorien van der Schaft, Judith L. Thijs, Marie L. A. Schuttelaar, Femke van Wijk, Edward F. Knol, Deepak M.W. Balak, Marijke R. van Dijk, Marjolein de Bruin‐Weller
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak M.W. Balak, Margreet L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia C. A. van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Daphne S. Bakker, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Femke van Wijk, Marjolein de Bruin‐Weller, Julia Drylewicz, Judith L. Thijs